Correlation Between Kamada and Vir Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kamada and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kamada and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kamada and Vir Biotechnology, you can compare the effects of market volatilities on Kamada and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kamada with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kamada and Vir Biotechnology.

Diversification Opportunities for Kamada and Vir Biotechnology

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kamada and Vir is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Kamada and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Kamada is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kamada are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Kamada i.e., Kamada and Vir Biotechnology go up and down completely randomly.

Pair Corralation between Kamada and Vir Biotechnology

Given the investment horizon of 90 days Kamada is expected to under-perform the Vir Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Kamada is 2.2 times less risky than Vir Biotechnology. The stock trades about -0.02 of its potential returns per unit of risk. The Vir Biotechnology is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  452.00  in Vir Biotechnology on August 15, 2025 and sell it today you would earn a total of  95.00  from holding Vir Biotechnology or generate 21.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kamada  vs.  Vir Biotechnology

 Performance 
       Timeline  
Kamada 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Kamada has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Kamada is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Vir Biotechnology 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent forward indicators, Vir Biotechnology reported solid returns over the last few months and may actually be approaching a breakup point.

Kamada and Vir Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kamada and Vir Biotechnology

The main advantage of trading using opposite Kamada and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kamada position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.
The idea behind Kamada and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals